0001662579-23-000114.txt : 20231120 0001662579-23-000114.hdr.sgml : 20231120 20231120162134 ACCESSION NUMBER: 0001662579-23-000114 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231116 FILED AS OF DATE: 20231120 DATE AS OF CHANGE: 20231120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hughes Owen CENTRAL INDEX KEY: 0001575933 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39567 FILM NUMBER: 231423050 MAIL ADDRESS: STREET 1: C/O RADIUS HEALTH, INC. STREET 2: 201 BROADWAY, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: C4 Therapeutics, Inc. CENTRAL INDEX KEY: 0001662579 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475617627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 120 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: (617) 231-0700 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 120 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 wk-form4_1700515278.xml FORM 4 X0508 4 2023-11-16 0 0001662579 C4 Therapeutics, Inc. CCCC 0001575933 Hughes Owen C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY #120 WATERTOWN MA 02472 1 0 0 0 0 Stock Option (Right to Buy) 1.82 2023-11-16 4 A 0 52000 0 A 2033-11-15 Common Stock 52000 52000 D 33% of the shares underlying this option shall vest and become exercisable on November 16, 2024, with the remainder vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. /s/ Jolie M. Siegel, Attorney-in-Fact 2023-11-20